Spine Biologics Market worth $2.4 Billion by 2020

1
MarketsandMarkets Presents
Spine Biologics Market worth 2.4 Billion by 2020
http//www.marketsandmarkets.com/Market-Reports/sp
ine-biologics-market-67680943.html
2
The report "Spine Biologics Market by Product
Type (Bone Graft, Bine Graft Substitute, Platelet
Rich Plasma, BMAC), Surgery Type (Anterior
Cervical Discectomy and Fusion, Posterior Lumbar
Interbody Fusion), End User, and Geography -
Global Forecast to 2020", the global spine
biologics market was valued at 1.90 Billion in
2014 and is expected to reach 2.4 Billion by
2020, at a CAGR of 4.4 during the forecast
period of 2015 to 2020. Browse 55 market data
tables and 54 figures spread through 101 pages
and in-depth TOC on "Spine Biologics
Market http//www.marketsandmarkets.com/Market-Re
ports/spine-biologics-market-67680943.html Early
buyers will receive 10 customization on This
report.   Spinal biologics encompass materials
that can be utilized in case of bone fusion
surgery, spinal cord injury, and degenerative
disk disease. Ten years ago, the spine treatment
market constituted 75 traditional rods and
plates made of metals and 25 biologics
http//www.marketsandmarkets.com/Market-Reports/sp
ine-biologics-market-67680943.html
3
However, since metals are inert materials, they
did not stimulate the bone regeneration process.
On the other hand, biological materials are
proteins that can attract and stimulate cells,
promote fusion, and help in the bone healing
process By product type, the spine biologics
market is categorized into four types, namely,
bone graft substitutes, bone grafts,
platelet-rich plasma (PRP), and bone marrow
aspirate concentrate therapy. In 2014, the bone
graft substitutes segment contributed the largest
share of 84.1 to the global market. By surgery
type, the market is segmented into anterior
cervical discectomy and fusion (ACDF),
transforaminal lumbar interbody fusion (TLIF),
anterior lumbar interbody fusion (ALIF), lateral
lumbar interbody fusion (LLIF), and other
surgeries. The ACDF segment contributed the
largest share to the global spine biologics
market in 2014, followed by the transforaminal
lumbar interbody fusion (TLIF) segment.
http//www.marketsandmarkets.com/Market-Reports/sp
ine-biologics-market-67680943.html
4
The spine biologics devices are used in spine
surgery as lieu allografts as well as a support
for bones in and around the spinal region. These
devices offer numerous benefits over materials
such as pedicle rods and screws that are used in
spine fusion Since metals are inert in nature,
they do not stimulate or activate cellular growth
or alter cellular functions such as natural
healing. The Sample Report For This Report_at_
http//www.marketsandmarkets.com/requestsample.as
p?id67680943 Spine biologics, on the other
hand, activate cellular growth by stimulating
spine fusion. The driving forces for global
spinal biologics market include rising incidence
of spinal disorders, rising healthcare
expenditure in developing nations owing to
growing income levels, rising obesity cases,
awareness on the newly developed spine treatment
techniques and devices, technological
advancements, and rising demand of minimally
invasive spine surgeries. The major restraints
for this market include lack of expertise, lack
of patient awareness, cost of surgery, and
unfavourable reimbursement scenario.    
http//www.marketsandmarkets.com/Market-Reports/sp
ine-biologics-market-67680943.html
5
The global spine biologics market has been
categorized by regions into North America,
Europe, Asia-Pacific, and the Rest of the World.
North America is the most dominant region in the
global market, followed by Europe. Bone graft
substitute segment dominated the North American
spine biologics market. Get The PDF Brochure For
This Report_at_ http//www.marketsandmarkets.com/pdfd
ownload.asp?id67680943 Some of the major
players in the spine biologics market are
Medtronic Inc. (U.S.), DePuy Synthes Companies
(U.S.), Zimmer Holding Inc. (U.S.), Nuvasive Inc.
(U.S.), Stryker Corporation (U.S.), Orthofix
international N.V. (U.S.), K2M Inc. (U.S.),
Exactech Inc. (U.S.), Wright Medical Technology
Inc. (U.S.), and others.      
http//www.marketsandmarkets.com/Market-Reports/sp
ine-biologics-market-67680943.html
6
About MarketsandMarkets MarketsandMarkets
provides quantified B2B research on 30,000 high
growth niche opportunities/threats which will
impact 70 to 80 of worldwide companies
revenues. Currently servicing 5000 customers
worldwide including 80 of global Fortune 1000
companies as clients. Almost 75,000 top officers
across eight industries worldwide approach
MarketsandMarkets for their painpoints around
revenues decisions.   Our 850 fulltime analyst
and SMEs at MarketsandMarkets are tracking
global high growth markets following the "Growth
Engagement Model GEM". The GEM aims at
proactive collaboration with the clients to
identify new opportunities, identify most
important customers, write "Attack, avoid and
defend" strategies, identify sources of
incremental revenues for both the company and its
competitors. MarketsandMarkets now coming up
with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies,
innovators, strategic players) annually in high
growth emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve.   MarketsandMarketss flagship
competitive intelligence and market research
platform, "RT" connects over 200,000 markets and
entire value chains for deeper understanding of
the unmet insights along with market sizing and
forecasts of niche markets.   
http//www.marketsandmarkets.com/Market-Reports/sp
ine-biologics-market-67680943.html
7
Contact Us
Mr. Rohan MarketsandMarkets 701 Pike Street
Suite 2175, Seattle, WA 98101, United States
Tel [phone] Email sales_at_marketsandmarket
s.com MarketsandMarkets Bloghttp//www.marketsan
dmarkets.comhttp//twitter.com/marketsmarkets htt
p//www.linkedin.com/company/marketsandmarkets